IBM Watson Health Invests in Research Collaborations with Leading Medical Centers to Advance the...
IBM Watson Health (NYSE: IBM) today announced plans to make a 10-year, $50 million investment in research collaborations with two separate academic centers - Brigham and Women's Hospital, which is...
OneTouch® Blood Glucose Monitoring System Accuracy Proven in New Long-Term Study
Research demonstrates clinical accuracy of OneTouch Select Plus® platform, and demonstrates the value of a continuous and systematic testing program to verify product performance for as long...
Deep Brain Stimulation Offers Fresh Hope for Parkinson’s Patients
Deep brain stimulation (DBS) uses a battery-operated medical device to treat a variety of debilitating symptoms of Parkinson's disease, as well as essential tremor and dystonia, which...
Clinical Trials Planned for Iris-Recognition-Based Patient Identification Software
Patientory, Inc. and IrisGuard collaborate to address patient identity challenges across the healthcare system to deliver greater clinical, financial, and administrative efficiencies
Today, Patientory Inc. and UK-based IrisGuard...
First-time Data Unveiled at the 31st Annual International Symposium on Endovascular Therapy
First in Human Stem Cell Trial for Hemodialysis AVF Yields Promising Results
The International Symposium on Endovascular Therapy (ISET), today announced that more than 20 highly anticipated research...
New Four-Year Data Demonstrate Rezūm™ Water Vapor Therapy Offers Significant Durable Improvement of Benign...
Boston Scientific Corporation (NYSE: BSX) today announced that data from a randomized clinical trial demonstrate that Rezūm™ Water Vapor Therapy, a minimally invasive treatment for benign prostatic...
Bodyscan: 6,000 Scans Show Fat Mass Index (FMI) Is the True Measure of Body...
Technology measures fat to within a single gram
Bodyscan has revealed that body mass index or even body fat percentages are not the best measures of body fat,...
Swiss Enrollment Begins for FLEX Vessel Preparation System: The BELONG Study
VentureMed Group, Inc., a medical device company that develops and markets innovative interventional vascular solutions, announced enrollment of the first patients in the BELONG Study – BEnefit...
EU and Canada Award €8.4 Million to iReceptor Plus Project to Ease Genomic and...
The new collaborative international project headed by Bar-Ilan University aims to promote human immunological data storage, integration and controlled sharing to enable personalized medicine
The European Union (EU)...
CSA Medical’s truFreeze® Spray Cryotherapy Highlighted at New York Society for Gastrointestinal Endoscopy Annual...
Spray Cryotherapy Ablation procedure shared "live" and in real time demonstrates the use of Rapid AV Catheter in Esophageal Cancer
CSA Medical announced the first live case highlighting...
